Cargando…

Epigenome-wide association study of bronchopulmonary dysplasia in preterm infants: results from the discovery-BPD program

BACKGROUND: Bronchopulmonary dysplasia (BPD) is a lung disease in premature infants caused by therapeutic oxygen supplemental and characterized by impaired pulmonary development which persists into later life. While advances in neonatal care have improved survival rates of premature infants, cases o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xuting, Cho, Hye-Youn, Campbell, Michelle R., Panduri, Vijayalakshmi, Coviello, Silvina, Caballero, Mauricio T., Sambandan, Deepa, Kleeberger, Steven R., Polack, Fernando P., Ofman, Gaston, Bell, Douglas A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052529/ https://www.ncbi.nlm.nih.gov/pubmed/35484630 http://dx.doi.org/10.1186/s13148-022-01272-0

Ejemplares similares

Prospective epigenome and transcriptome analyses of cord and peripheral blood from preterm infants at risk of bronchopulmonary dysplasia
por: Cho, Hye-Youn, et al.
Publicado: (2023)

Effect of Montelukast on Bronchopulmonary Dysplasia (BPD) and Related Mechanisms
por: Chen, Xin, et al.
Publicado: (2019)

Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns
por: Omar, Said A., et al.
Publicado: (2022)

Systemic Steroids in Preventing Bronchopulmonary Dysplasia (BPD): Neurodevelopmental Outcome According to the Risk of BPD in the EPICE Cohort
por: Zayat, Noura, et al.
Publicado: (2022)

Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study): statistical analysis plan
por: Onland, Wes, et al.
Publicado: (2018)

Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study
por: van Katwyk, Sasha, et al.
Publicado: (2020)

Chitin-Derived AVR-48 Prevents Experimental Bronchopulmonary Dysplasia (BPD) and BPD-Associated Pulmonary Hypertension in Newborn Mice
por: Das, Pragnya, et al.
Publicado: (2021)

The discovery BPD (D-BPD) program: study protocol of a prospective translational multicenter collaborative study to investigate determinants of chronic lung disease in very low birth weight infants
por: Ofman, Gaston, et al.
Publicado: (2019)

Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD)
por: Löfqvist, Chatarina, et al.
Publicado: (2012)

Systemic hydrocortisone to prevent bronchopulmonary dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial
por: Onland, Wes, et al.
Publicado: (2011)

Biomarkers for Bronchopulmonary Dysplasia in the Preterm Infant
por: Rivera, Lidys, et al.
Publicado: (2016)

Respiratory Morbidity and Lung Function Analysis During the First 36 Months of Life in Infants With Bronchopulmonary Dysplasia (BPD)
por: Chen, Dandan, et al.
Publicado: (2020)

A comparison of newer classifications of bronchopulmonary dysplasia: findings from the Children’s Hospitals Neonatal Consortium Severe BPD Group
por: Vyas-Read, Shilpa, et al.
Publicado: (2021)

New BPD-prevalence and risk factors for bronchopulmonary dysplasia/mortality in extremely low gestational age infants ≤28 weeks
por: Geetha, Odattil, et al.
Publicado: (2021)

Pulmonary Hypertension in Preterm Infants With Bronchopulmonary Dysplasia
por: An, Hyo Soon, et al.
Publicado: (2010)

Nutrition of preterm infants in relation to bronchopulmonary dysplasia
por: Wemhöner, Andreas, et al.
Publicado: (2011)

Vitamin D and bronchopulmonary dysplasia in preterm infants
por: Joung, K E, et al.
Publicado: (2016)

Prediction Model for Bronchopulmonary Dysplasia in Preterm Newborns
por: Jassem-Bobowicz, Joanna Maria, et al.
Publicado: (2021)

Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System †
por: Chao, Cho-Ming, et al.
Publicado: (2020)

Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis
por: Lan, Jiang, et al.
Publicado: (2023)

Initial respiratory management in preterm infants and bronchopulmonary dysplasia
por: López, Ester Sanz, et al.
Publicado: (2011)

Bronchopulmonary dysplasia and neurodevelopmental outcome in extremely preterm neonates
por: Trittmann, J. K., et al.
Publicado: (2013)

Association between anemia and bronchopulmonary dysplasia in preterm infants
por: Duan, Jun, et al.
Publicado: (2016)

Evidence for the Management of Bronchopulmonary Dysplasia in Very Preterm Infants
por: Muehlbacher, Tobias, et al.
Publicado: (2021)

Association between probiotics and bronchopulmonary dysplasia in preterm infants
por: Qu, Yangming, et al.
Publicado: (2021)

Risk Factors for Tracheobronchomalacia in Preterm Infants With Bronchopulmonary Dysplasia
por: Su, Ya-Ting, et al.
Publicado: (2021)

Respiratory Tract Microecology and Bronchopulmonary Dysplasia in Preterm Infants
por: Sun, Tong, et al.
Publicado: (2021)

The nasal microbiome of predicting bronchopulmonary dysplasia in preterm infants
por: Xu, Yanping, et al.
Publicado: (2022)

Lymphocyte-Specific Biomarkers Associated With Preterm Birth and Bronchopulmonary Dysplasia
por: Bhattacharya, Soumyaroop, et al.
Publicado: (2021)

BPD, Not BPD, or Iatrogenic BPD: Findings of Lung Ultrasound Examinations
por: Liu, Jing, et al.
Publicado: (2014)

Air quality, Environment and Respiratory Outcomes in Bronchopulmonary Dysplasia, the AERO-BPD cohort study: design and adaptation during the SARS-CoV-2 pandemic
por: Ruran, Hana B, et al.
Publicado: (2021)

Ceramides in tracheal aspirates of preterm infants: Marker for bronchopulmonary dysplasia
por: van Mastrigt, Esther, et al.
Publicado: (2018)

Airway nitrite is increased in extremely preterm infants with bronchopulmonary dysplasia
por: Gentle, Samuel J., et al.
Publicado: (2020)

Management of total intravenous anaesthesia in preterm neonates with bronchopulmonary dysplasia
por: Quintero, Carlos, et al.
Publicado: (2020)

The Correlation Between Bronchopulmonary Dysplasia and Platelet Metabolism in Preterm Infants
por: Yan, Longli, et al.
Publicado: (2021)

The Change of Cytokines and Gut Microbiome in Preterm Infants for Bronchopulmonary Dysplasia
por: Zhang, Zhenjie, et al.
Publicado: (2022)

Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia
por: Htun, Zeyar T., et al.
Publicado: (2021)

Risk prediction of bronchopulmonary dysplasia in preterm infants by the nomogram model
por: Gao, Yang, et al.
Publicado: (2023)

Exploring right ventricular function applicability in a prediction model to identify preterm infants with early bronchopulmonary dysplasia (REPORT-BPD study): a mixed-methods observational cohort feasibility study protocol
por: Muhsen, Wisam S., et al.
Publicado: (2022)

The high-risk factors of different severities of bronchopulmonary dysplasia (BPD) based on the national institute of child health and human development (NICHD) diagnosis criteria in 2018
por: Jian, Minqiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m6nslp9j4uidmni189lc7hu9pm